Results 311 to 320 of about 4,863,715 (431)
Hepatic T cell lymphoma after chimeric antigen receptor T cell therapy for myeloma
Joshua Mehr, Mingyi Chen
doaj +1 more source
The intratumoral landscape of T cell receptor repertoire in esophageal squamous cell carcinoma. [PDF]
Yang M+6 more
europepmc +1 more source
MIF as an oncogenic driver of low‐heterogeneity melanomas
Shvefel and colleagues identified tumor‐secreted macrophage migration inhibitory factor (MIF) as an upregulated cytokine that mediates immune resistance in melanomas with low‐intratumoral heterogeneity. MIF and its functional paralogue D‐dopachrome tautomerase (D‐DT or MIF‐2) have overlapping but nonidentical signaling functions and are hypothesized to
Thuy T. Tran+4 more
wiley +1 more source
A naturally selected αβ T cell receptor binds HLA-DQ2 molecules without co-contacting the presented peptide. [PDF]
Lim JJ+7 more
europepmc +1 more source
Linking T-cell receptor sequence to functional phenotype at the single-cell level
A. Han+3 more
semanticscholar +1 more source
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez+17 more
wiley +1 more source
Ubiquitination of transcription factors in cancer: unveiling therapeutic potential
In cancer, dysregulated ubiquitination of transcription factors contributes to the uncontrolled growth and survival characteristics of tumors. Tumor suppressors are degraded by aberrant ubiquitination, or oncogenic transcription factors gain stability through ubiquitination, thereby promoting tumorigenesis.
Dongha Kim, Hye Jin Nam, Sung Hee Baek
wiley +1 more source
Synthetic T-Cell Receptor-like Protein Behaves as a Janus Particle in Solution. [PDF]
Sakamoto-Rablah E+5 more
europepmc +1 more source